BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, Ostergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage. 2001;9:203-214. [PMID: 11300743 DOI: 10.1053/joca.2000.0377] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Dündar Ü, Aşık G, Ulaşlı AM, Sınıcı Ş, Yaman F, Solak Ö, Toktaş H, Eroğlu S. Assessment of pulsed electromagnetic field therapy with Serum YKL-40 and ultrasonography in patients with knee osteoarthritis. Int J Rheum Dis 2016;19:287-93. [DOI: 10.1111/1756-185x.12565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Dehn H, Høgdall EVS, Johansen JS, Jørgensen M, Price PA, Engelholm SAA, Høgdall CK. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer: YKL-40 and ovarian cancer. Acta Obstetricia et Gynecologica Scandinavica 2003;82:287-93. [DOI: 10.1034/j.1600-0412.2003.00010.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
3 De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285:926-931. [PMID: 11467840 DOI: 10.1006/bbrc.2001.5253] [Cited by in Crossref: 125] [Cited by in F6Publishing: 125] [Article Influence: 6.0] [Reference Citation Analysis]
4 Rhodes LA, Keenan AM, Grainger AJ, Emery P, McGonagle D, Conaghan PG. The relationship between limited MRI section analyses and volumetric assessment of synovitis in knee osteoarthritis. Clin Radiol 2005;60:1295-9. [PMID: 16291311 DOI: 10.1016/j.crad.2005.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
5 Tehranzadeh J, Ashikyan O, Dascalos J, Dennehey C. Advanced imaging of early rheumatoid arthritis. Magnetic Resonance Imaging Clinics of North America 2004;12:707-26. [DOI: 10.1016/j.mric.2004.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Iwata M, Ochi H, Asou Y, Haro H, Aikawa T, Harada Y, Nezu Y, Yogo T, Tagawa M, Hara Y. Variations in gene and protein expression in canine chondrodystrophic nucleus pulposus cells following long-term three-dimensional culture. PLoS One 2013;8:e63120. [PMID: 23658803 DOI: 10.1371/journal.pone.0063120] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
7 Bevilacqua M, Devogelaer J, Rig Mini V, Famaey J, Mancourt D. Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study. International Journal of Clinical Practice 2004;58:13-9. [DOI: 10.1111/j.1742-1241.2004.013_c.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Grainger AJ, Rhodes LA, Keenan A, Emery P, Conaghan PG. Quantifying peri-meniscal synovitis and its relationship to meniscal pathology in osteoarthritis of the knee. Eur Radiol 2007;17:119-24. [DOI: 10.1007/s00330-006-0282-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
9 Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, Johansen JS. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008;19:257-63. [PMID: 18480670 DOI: 10.1097/MCA.0b013e3282f40dd5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
10 South S, Lucero J, Vijayagopal P, Juma S. Anti-Inflammatory Action of Blueberry Polyphenols in HIG-82 Rabbit Synoviocytes. Journal of Medicinal Food 2019;22:1032-40. [DOI: 10.1089/jmf.2019.0046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Fukui N, Purple CR, Sandell LJ. Cell biology of osteoarthritis: The chondrocyte’s response to injury. Curr Rheumatol Rep 2001;3:496-505. [DOI: 10.1007/s11926-001-0064-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
12 Petersson M, Bucht E, Granberg B, Stark A. Effects of arginine-vasopressin and parathyroid hormone-related protein (1–34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis. Osteoarthritis and Cartilage 2006;14:652-9. [DOI: 10.1016/j.joca.2006.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
13 El-asrar MA, Elbarbary NS, Ismail EAR, Elshenity AM. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications. Blood Cells, Molecules, and Diseases 2016;56:1-8. [DOI: 10.1016/j.bcmd.2015.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Johansen JS, Krabbe KS, Møller K, Pedersen BK. Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol. 2005;140:343-348. [PMID: 15807860 DOI: 10.1111/j.1365-2249.2005.02763.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
15 Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med. 2005;99:396-402. [PMID: 15763444 DOI: 10.1016/j.rmed.2004.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
16 Mylin AK, Rasmussen T, Johansen JS, Knudsen LM, Nørgaard PH, Lenhoff S, Dahl IM, Johnsen HE. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol. 2006;77:416-424. [PMID: 16930142 DOI: 10.1111/j.0902-4441.2006.t01-1-ejh2879.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Parsons S, Alesci S, Feuerstein G, Wang J. Biomarkers in the development of novel disease-modifying therapies for osteoarthritis. Biomarkers in Medicine 2008;2:587-602. [DOI: 10.2217/17520363.2.6.587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
18 Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E; NEO-RACo Study Group. Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PLoS One 2017;12:e0183294. [PMID: 28841649 DOI: 10.1371/journal.pone.0183294] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
19 Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21. [PMID: 12889595 DOI: 10.1023/A:1024431000710] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
20 Steck E, Breit S, Breusch SJ, Axt M, Richter W. Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun. 2002;299:109-115. [PMID: 12435396 DOI: 10.1016/s0006-291x(02)02585-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
21 Bohr S, Patel SJ, Vasko R, Shen K, Golberg A, Berthiaume F, Yarmush ML. The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model. PLoS One 2015;10:e0140440. [PMID: 26528713 DOI: 10.1371/journal.pone.0140440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
22 Perez MF, Atuegwu NC, Mortensen EM, Oncken C. The inflammatory biomarker YKL-40 is elevated in the serum, but not the sputum, of E-cigarette users. Exp Lung Res 2021;47:55-66. [PMID: 33200966 DOI: 10.1080/01902148.2020.1847216] [Reference Citation Analysis]
23 Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, Friis T, Bindslev L, Haack-Sørensen M, Jørgensen E, Kastrup J. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J. 2008;42:295-302. [PMID: 18615353 DOI: 10.1080/14017430802220567] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
24 Watanabe K, Shiga K, Maeda A, Harata S, Yanagita T, Suzuki T, Ushigome H, Maeda Y, Hirokawa T, Ogawa R, Hara M, Takahashi H, Matsuo Y, Mitsui A, Kimura M, Takiguchi S. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer. Int J Oncol 2022;60:3. [PMID: 34913066 DOI: 10.3892/ijo.2021.5293] [Reference Citation Analysis]
25 Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 2009;37:18-24. [PMID: 19215669 DOI: 10.1177/147323000903700102] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
26 Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009;511:159-84. [PMID: 19347297 DOI: 10.1007/978-1-59745-447-6_7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
27 Rivas-Alarcón AA, Gómez-Gómez Y, Organista-Nava J, Jiménez-López MA, Rivera-Ramírez AB, Ibarra-Sierra E, Saavedra-Herrera MV, Illades-Aguiar B, Leyva-Vázquez MA. Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia. Mol Clin Oncol 2021;15:168. [PMID: 34194746 DOI: 10.3892/mco.2021.2330] [Reference Citation Analysis]
28 Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opinion on Therapeutic Targets 2007;11:219-34. [DOI: 10.1517/14728222.11.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
29 Schmidt H, Johansen JS, Sjoegren P, Christensen IJ, Sorensen BS, Fode K, Larsen J, von der Maase H. Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma. JCO 2006;24:798-804. [DOI: 10.1200/jco.2005.03.7960] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
30 Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704 [PMID: 29209110 DOI: 10.3748/wjg.v23.i43.7693] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
31 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
32 Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231. [PMID: 15829322 DOI: 10.1016/j.lungcan.2004.11.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
33 Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AÖ, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS One 2011;6:e24399. [PMID: 21949714 DOI: 10.1371/journal.pone.0024399] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
34 Mathiasen AB, Harutyunyan MJ, Jørgensen E, Helqvist S, Ripa R, Gøtze JP, Johansen JS, Kastrup J. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 2011;71:439-47. [DOI: 10.3109/00365513.2011.586470] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
35 Lee CG, Elias JA. Role of breast regression protein-39/YKL-40 in asthma and allergic responses. Allergy Asthma Immunol Res 2010;2:20-7. [PMID: 20224674 DOI: 10.4168/aair.2010.2.1.20] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
36 Rhodes LA, Grainger AJ, Keenan AM, Thomas C, Emery P, Conaghan PG. The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis. Rheumatology (Oxford) 2005;44:1569-73. [PMID: 16188949 DOI: 10.1093/rheumatology/kei094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
37 Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol 2013;4:122. [PMID: 23755018 DOI: 10.3389/fphys.2013.00122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
38 Wang D, Lu JG, Wang Q, Du XL, Dong R, Wang P, Zhao L, Jiang X, Yuan LJ. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension. Braz J Med Biol Res 2012;45:264-72. [PMID: 22267006 DOI: 10.1590/s0100-879x2012007500010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
39 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
40 Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P, Fan H. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:409-18. [PMID: 29430175 DOI: 10.2147/COPD.S152655] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
41 Punzi L, Oliviero F, Plebani M. New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment. Crit Rev Clin Lab Sci. 2005;42:279-309. [PMID: 16281737 DOI: 10.1080/10408360591001886] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
42 Einarsson JM, Bahrke S, Sigurdsson BT, Ng CH, Petersen PH, Sigurjonsson OE, Jonsson H Jr, Gislason J, Thormodsson FR, Peter MG. Partially acetylated chitooligosaccharides bind to YKL-40 and stimulate growth of human osteoarthritic chondrocytes. Biochem Biophys Res Commun 2013;434:298-304. [PMID: 23541584 DOI: 10.1016/j.bbrc.2013.02.122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
43 Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 2006;281:21082-95. [PMID: 16704970 DOI: 10.1074/jbc.M601153200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
44 Bi J, Lau SH, Lv ZL, Xie D, Li W, Lai YR, Zhong JM, Wu HQ, Su Q, He YL. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Hum Pathol. 2009;40:1790-1797. [PMID: 19765801 DOI: 10.1016/j.humpath.2009.07.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
45 Mansell J, Cooke M, Read M, Rudd H, Shiel A, Wilkins K, Manso M. Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3. Biochimie 2016;128-129:193-200. [DOI: 10.1016/j.biochi.2016.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
46 Shostak K, Labunskyy V, Dmitrenko V, Malisheva T, Shamayev M, Rozumenko V, Zozulya Y, Zehetner G, Kavsan V. HC gp-39 gene is upregulated in glioblastomas. Cancer Letters 2003;198:203-10. [DOI: 10.1016/s0304-3835(03)00310-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
47 Ober C, Chupp GL. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 2009;9:401-8. [PMID: 19644363 DOI: 10.1097/ACI.0b013e3283306533] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
48 Punzi L, Oliviero F, Ramonda R, Valvason C, Sfriso P, Todesco S. Laboratory investigations in osteoarthritis. Aging Clin Exp Res 2003;15:373-9. [DOI: 10.1007/bf03327358] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
49 Meredith DS, Losina E, Neumann G, Yoshioka H, Lang PK, Katz JN. Empirical evaluation of the inter-relationship of articular elements involved in the pathoanatomy of knee osteoarthritis using magnetic resonance imaging. BMC Musculoskelet Disord. 2009;10:133. [PMID: 19874594 DOI: 10.1186/1471-2474-10-133] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
50 Kacira T, Hanimoglu H, Kucur M, Sanus GZ, Kafadar AM, Tanriverdi T, Kaynar MY. Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2008;15:1011-6. [PMID: 18280741 DOI: 10.1016/j.jocn.2006.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
51 Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479-501. [PMID: 21054166 DOI: 10.1146/annurev-physiol-012110-142250] [Cited by in Crossref: 471] [Cited by in F6Publishing: 471] [Article Influence: 42.8] [Reference Citation Analysis]
52 Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2014;32:663-9. [DOI: 10.1016/j.urolonc.2014.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
53 Ho YY, Baron M, Recklies AD, Roughley PJ, Mort JS. Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. BBA Clin 2014;1:2-11. [PMID: 26675476 DOI: 10.1016/j.bbacli.2013.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
54 Deutschmann C, Sowa M, Murugaiyan J, Roesler U, Röber N, Conrad K, Laass MW, Bogdanos D, Sipeki N, Papp M, Rödiger S, Roggenbuck D, Schierack P. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease. J Crohns Colitis 2019;13:894-904. [PMID: 30753386 DOI: 10.1093/ecco-jcc/jjz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
55 Jiang Y, Zhang G, Wang Z, Yang H. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage. Clinical Biochemistry 2014;47:302-6. [DOI: 10.1016/j.clinbiochem.2014.09.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
56 Musumeci M, Caruso V, Medulla E, Torrisi V, Migale R, Angeletti S, Musumeci S. Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major. Dis Markers 2014;2014:965971. [PMID: 24808626 DOI: 10.1155/2014/965971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Degroot J, Bank RA, Tchetverikov I, Verzijl N, Tekoppele JM. Molecular markers for osteoarthritis: the road ahead: . Current Opinion in Rheumatology 2002;14:585-9. [DOI: 10.1097/00002281-200209000-00019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
58 Schultz NA, Johansen JS. YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) 2010;2:1453-91. [PMID: 24281168 DOI: 10.3390/cancers2031453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
59 Kastrup J. Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 2012;217:483-91. [DOI: 10.1016/j.imbio.2011.04.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
60 Hoover DJ, Zhu V, Chen R, Briley K, Rameshwar P, Cohen S, Coffman FD. Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells. PLoS One. 2013;8:e62491. [PMID: 23671604 DOI: 10.1371/journal.pone.0062491] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
61 Singh S, Choudhary S, Anand V, Jaswal S, Verma AK, Kumar S, Kaushik JK, Mohanty AK. New insights into the catalytic inactivity of mammary gland protein-40, a chitinase-like protein expressed during mammary gland involution. Mol Biol Rep 2019;46:2243-57. [DOI: 10.1007/s11033-019-04679-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Science 2005;96:183-90. [DOI: 10.1111/j.1349-7006.2005.00026.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
63 Furuhashi K, Suda T, Nakamura Y, Inui N, Hashimoto D, Miwa S, Hayakawa H, Kusagaya H, Nakano Y, Nakamura H, Chida K. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 2010;104:1204-10. [PMID: 20347285 DOI: 10.1016/j.rmed.2010.02.026] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
64 Egberts F, Kotthoff EM, Gerdes S, Egberts JH, Weichenthal M, Hauschild A. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma. Eur J Cancer 2012;48:695-702. [PMID: 21917447 DOI: 10.1016/j.ejca.2011.08.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
65 Kazakova M, Batalov A, Deneva T, Mateva N, Kolarov Z, Sarafian V. Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis. Rheumatol Int 2013;33:341-6. [PMID: 22451025 DOI: 10.1007/s00296-012-2387-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
66 Jönsson M, Gerdle B, Ghafouri B, Bäckryd E. The inflammatory profile of cerebrospinal fluid, plasma, and saliva from patients with severe neuropathic pain and healthy controls-a pilot study. BMC Neurosci 2021;22:6. [PMID: 33522900 DOI: 10.1186/s12868-021-00608-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Mathiasen AB, Henningsen KMA, Harutyunyan MJ, Mygind ND, Kastrup J. YKL-40: a new biomarker in cardiovascular disease? Biomarkers in Medicine 2010;4:591-600. [DOI: 10.2217/bmm.10.58] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
68 Kzhyshkowska J, Gudima A, Moganti K, Gratchev A, Orekhov A. Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic Inflammation. Transfus Med Hemother 2016;43:66-77. [PMID: 27226789 DOI: 10.1159/000444943] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
69 Scully S, Yan W, Bentley B, Cao QJ, Shao R. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One 2011;6:e25819. [PMID: 21991364 DOI: 10.1371/journal.pone.0025819] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
70 Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82. [PMID: 19792974 DOI: 10.2217/fon.09.66] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 7.4] [Reference Citation Analysis]
71 Arjmandi B, Khalil D, Lucas E, Smith B, Sinichi N, Hodges S, Juma S, Munson M, Payton M, Tivis R, Svanborg A. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine 2004;11:567-75. [DOI: 10.1016/j.phymed.2003.11.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
72 van Lierop MJ, den Hoed L, Houbiers J, Vencovsky J, Ruzickova S, Krystufkova O, van Schaardenburg M, van den Hoogen F, Vandooren B, Baeten D, De Keyser F, Sønderstrup G, Bos E, Boots AM. Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint. Arthritis Rheum 2007;56:2150-9. [PMID: 17599744 DOI: 10.1002/art.22651] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
73 He B, Wang L, Wang J, Li G, Zhang S. Positive selection of three chitinase genes of the family 18 of glycoside hydrolases in mammals. Biologia 2009;64:819-25. [DOI: 10.2478/s11756-009-0117-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Qin W, Zhu W, Schlatter L, Miick R, Loy TS, Atasoy U, Hewett JE, Sauter ER. Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer 2007;121:1536-42. [PMID: 17565739 DOI: 10.1002/ijc.22881] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
75 Conaghan P, Felson D, Gold G, Lohmander S, Totterman S, Altman R. MRI and non-cartilaginous structures in knee osteoarthritis. Osteoarthritis and Cartilage 2006;14:87-94. [DOI: 10.1016/j.joca.2006.02.028] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
76 Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T, Hansen AB. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 2010;57:371-83. [PMID: 20840668 DOI: 10.1111/j.1365-2559.2010.03640.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
77 Rolle NA, Jan I, Sibbitt WL Jr, Band PA, Haseler LJ, Hayward WA, Muruganandam M, Emil NS, Fangtham M, Bankhurst AD. Extractable synovial fluid in inflammatory and non-inflammatory arthritis of the knee. Clin Rheumatol 2019;38:2255-63. [PMID: 30953230 DOI: 10.1007/s10067-019-04524-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Shaker OG, Elbaz EM. Possible Prognostic Potential of RANKL and OPG in Metastatic Breast Cancer Egyptian Females. Asian Pac J Cancer Prev 2020;21:355-61. [PMID: 32102511 DOI: 10.31557/APJCP.2020.21.2.355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Zivanović S, Rackov LP, Vojvodić D, Vucetić D. Human cartilage glycoprotein 39--biomarker of joint damage in knee osteoarthritis. Int Orthop 2009;33:1165-70. [PMID: 19308408 DOI: 10.1007/s00264-009-0747-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
80 Zhu W, Lönnblom E, Förster M, Johannesson M, Tao P, Meng L, Lu S, Holmdahl R. Natural polymorphism of Ym1 regulates pneumonitis through alternative activation of macrophages. Sci Adv 2020;6:eaba9337. [PMID: 33087360 DOI: 10.1126/sciadv.aba9337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
81 Li TM, Liu SC, Huang YH, Huang CC, Hsu CJ, Tsai CH, Wang SW, Tang CH. YKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells. Int J Mol Sci 2017;18:E920. [PMID: 28448439 DOI: 10.3390/ijms18050920] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
82 Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007;18:391-6. [PMID: 17627189 DOI: 10.1097/MCA.0b013e328241d991] [Cited by in Crossref: 99] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
83 Naglot S, Aggarwal P, Dey S, Dalal K. Estimation of Serum YKL-40 by Real-Time Surface Plasmon Resonance Technology in North-Indian Asthma Patients. J Clin Lab Anal 2017;31. [PMID: 27616735 DOI: 10.1002/jcla.22028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 Kilic G, Kilic E, Akgul O, Ozgocmen S. Decreased femoral cartilage thickness in patients with systemic sclerosis. Am J Med Sci 2014;347:382-6. [PMID: 23928545 DOI: 10.1097/MAJ.0b013e31829a348b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
85 Wilson R, Belluoccio D, Little CB, Fosang AJ, Bateman JF. Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum 2008;58:3120-31. [PMID: 18821673 DOI: 10.1002/art.23789] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
86 Hooshmand S, Soung DY, Lucas EA, Madihally SV, Levenson CW, Arjmandi BH. Genistein reduces the production of proinflammatory molecules in human chondrocytes. The Journal of Nutritional Biochemistry 2007;18:609-14. [DOI: 10.1016/j.jnutbio.2006.11.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
87 Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006;65:1050-4. [PMID: 16396978 DOI: 10.1136/ard.2005.045914] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
88 Tsark EC, Wang W, Teng YC, Arkfeld D, Dodge GR, Kovats S. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. J Immunol. 2002;169:6625-6633. [PMID: 12444176 DOI: 10.4049/jimmunol.169.11.6625] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 2.8] [Reference Citation Analysis]
89 Trudel G, Recklies A, Laneuville O. Increased expression of chitinase 3-like protein 1 secondary to joint immobility. Clin Orthop Relat Res 2007;456:92-7. [PMID: 17194956 DOI: 10.1097/BLO.0b013e3180307c0a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
90 Schmid D, Warnken U, Latzer P, Hoffmann DC, Roth J, Kutschmann S, Jaschonek H, Rübmann P, Foltyn M, Vollmuth P, Winkler F, Seliger C, Felix M, Sahm F, Haas J, Reuss D, Bendszus M, Wildemann B, von Deimling A, Wick W, Kessler T. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. J Neurochem 2021;158:522-38. [PMID: 33735443 DOI: 10.1111/jnc.15350] [Reference Citation Analysis]
91 Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem 2007;55:1213-28. [PMID: 17712177 DOI: 10.1369/jhc.7A7245.2007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
92 Mizoguchi E, Mizoguchi A. Is the sugar always sweet in intestinal inflammation? Immunol Res 2007;37:47-60. [DOI: 10.1007/bf02686089] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
93 Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286:15332-15343. [PMID: 21385870 DOI: 10.1074/jbc.m110.212514] [Cited by in Crossref: 142] [Cited by in F6Publishing: 94] [Article Influence: 12.9] [Reference Citation Analysis]
94 Tuten A, Kucur M, Imamoglu M, Oncul M, Acikgoz AS, Sofiyeva N, Ozturk Z, Kaya B, Oral E. Serum YKL-40 levels are altered in endometriosis. Gynecol Endocrinol 2014;30:381-4. [PMID: 24533749 DOI: 10.3109/09513590.2014.887671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
95 Rani R, Singh V. Overexpression of YKL-40 (CHI3L1 gene) in patient fluids may be a potential predictive marker for early detection of comorbidity in non-communicable disease. Med Hypotheses 2020;143:110076. [PMID: 32721792 DOI: 10.1016/j.mehy.2020.110076] [Reference Citation Analysis]
96 Lee IA, Kamba A, Low D, Mizoguchi E. Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1127-1138 [PMID: 24574789 DOI: 10.3748/wjg.v20.i5.1127] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
97 Haglund L, Bernier SM, Önnerfjord P, Recklies AD. Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biology 2008;27:107-18. [DOI: 10.1016/j.matbio.2007.09.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
98 Tehranzadeh J, Ashikyan O, Dascalos J. Advanced imaging of early rheumatoid arthritis. Radiologic Clinics of North America 2004;42:89-107. [DOI: 10.1016/s0033-8389(03)00167-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
99 Yeo IJ, Lee CK, Han SB, Yun J, Hong JT. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther 2019;203:107394. [PMID: 31356910 DOI: 10.1016/j.pharmthera.2019.107394] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
100 Güngen G, Ardic F, Fιndıkoğlu G, Rota S. The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 2012;32:1235-44. [DOI: 10.1007/s00296-010-1727-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
101 Punzi L, Oliviero F, Ramonda R, Sfriso P, Todesco S. Laboratory Findings in Osteoarthritis. Seminars in Arthritis and Rheumatism 2004;34:58-61. [DOI: 10.1016/j.semarthrit.2004.03.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
102 Jafari-Nakhjavani MR, Ghorbanihaghjo A, Bagherzadeh-Nobari B, Malek-Mahdavi A, Rashtchizadeh N. Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis. Caspian J Intern Med 2019;10:92-7. [PMID: 30858947 DOI: 10.22088/cjim.10.1.92] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Kang EJ, Jung H, Woo OH, Park KH, Woo SU, Yang DS, Kim AR, Lee JB, Kim YH, Kim JS, Seo JH. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue. Tumour Biol 2014;35:277-86. [PMID: 23918300 DOI: 10.1007/s13277-013-1036-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
104 S. Johansen, John R. Kirwan, Paul A J. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Scandinavian Journal of Rheumatology 2009;30:297-304. [DOI: 10.1080/030097401753180381] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
105 Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 2007;15:371-81. [PMID: 18091378 DOI: 10.1097/01.pai.0000213146.77772.6a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
106 Hunter PJ, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, Wedderburn LR. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010;62:896-907. [PMID: 20127724 DOI: 10.1002/art.27284] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
107 Salomon J, Matusiak Ł, Nowicka-Suszko D, Szepietowski JC. Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis. Postepy Dermatol Alergol 2018;35:485-9. [PMID: 30429706 DOI: 10.5114/ada.2018.77239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
108 Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45:531-562. [PMID: 19003601 DOI: 10.1080/10408360802334743] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
109 Väänänen T, Koskinen A, Paukkeri EL, Hämäläinen M, Moilanen T, Moilanen E, Vuolteenaho K. YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints. Mediators Inflamm 2014;2014:215140. [PMID: 25132728 DOI: 10.1155/2014/215140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
110 Salomon J, Matusiak Ł, Nowicka-Suszko D, Szepietowski JC. Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis. J Immunol Res 2017;2017:5746031. [PMID: 28660216 DOI: 10.1155/2017/5746031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
111 Daghestani HN, Kraus VB. Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage 2015;23:1890-6. [PMID: 26521734 DOI: 10.1016/j.joca.2015.02.009] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 13.5] [Reference Citation Analysis]